advertisement
255
Showing records 1 to 25 | Display all abstracts from109213 Finding Ophthalmic Risk and Evaluating the Value of Eye exams and their predictive Reliability (FOREVER)-A cohort study in a Danish high street optician setting: Design and methodology
Freiberg J
Acta Ophthalmologica 2023; 0:
109649 Complications Occurring Through 5 Years Following Primary Intraocular Lens Implantation for Pediatric Cataract
Yen KG
JAMA ophthalmology 2023; 141: 705-714
109613 The Association of Physical Activity with Glaucoma and Related Traits in the UK Biobank
Madjedi KM
Ophthalmology 2023; 130: 1024-1036
109373 Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
Zeleznik OA
Nature communications 2023; 14: 2860
109317 Disentangling the genetic overlap and causal relationships between primary open-angle glaucoma, brain morphology and four major neurodegenerative disorders
Diaz-Torres S
EBioMedicine 2023; 92: 104615
110077 Differences in Factors Associated With Glaucoma Progression With Lower Normal Intraocular Pressure in Superior and Inferior Halves of the Optic Nerve Head
Asaoka R
Translational vision science & technology 2023; 12: 19
109864 Profile of Newly Diagnosed Childhood Glaucoma in India: ICGS 1
Kaushik S
Ophthalmology. Glaucoma 2024; 7: 54-65
109722 Large-scale multitrait genome-wide association analyses identify hundreds of glaucoma risk loci
Han X
Nature Genetics 2023; 55: 1116-1125
108767 Current practice in the management of ocular toxoplasmosis
Yogeswaran K
British Journal of Ophthalmology 2023; 107: 973-979
109940 High Myopia Normative Database of Peripapillary Retinal Nerve Fiber Layer Thickness to Detect Myopic Glaucoma in a Chinese Population
Song Y
Ophthalmology 2023; 130: 1279-1289
109233 Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology Consortium
Vergroesen JE
Ophthalmology 2023; 130: 893-906
109609 Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
Tanihara H
Advances in Therapy 2023; 40: 3559-3573
109312 Cost Utility and Value of Information Analysis of Femtosecond Laser-Assisted Cataract Surgery
Bénard A
JAMA ophthalmology 2023; 141: 625-629
109762 Cataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes
Jabs DA
American Journal of Ophthalmology 2023; 254: 210-220
109999 Glaucoma Treatment Patterns in Sub-Saharan Africa
Olawoye O
Journal of Glaucoma 2023; 32: 815-819
109773 Incidence of and Risk Factors for Cataract in Anterior Uveitis
Papaliodis GN
American Journal of Ophthalmology 2023; 254: 221-232
109373 Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
Kang JH
Nature communications 2023; 14: 2860
109773 Incidence of and Risk Factors for Cataract in Anterior Uveitis
Rosner BA
American Journal of Ophthalmology 2023; 254: 221-232
109613 The Association of Physical Activity with Glaucoma and Related Traits in the UK Biobank
Stuart KV
Ophthalmology 2023; 130: 1024-1036
109317 Disentangling the genetic overlap and causal relationships between primary open-angle glaucoma, brain morphology and four major neurodegenerative disorders
He W
EBioMedicine 2023; 92: 104615
109609 Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
Yamamoto T
Advances in Therapy 2023; 40: 3559-3573
109762 Cataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes
Sugar EA
American Journal of Ophthalmology 2023; 254: 210-220
109312 Cost Utility and Value of Information Analysis of Femtosecond Laser-Assisted Cataract Surgery
Sitta R
JAMA ophthalmology 2023; 141: 625-629
110077 Differences in Factors Associated With Glaucoma Progression With Lower Normal Intraocular Pressure in Superior and Inferior Halves of the Optic Nerve Head
Sakata R
Translational vision science & technology 2023; 12: 19
108767 Current practice in the management of ocular toxoplasmosis
Furtado JM
British Journal of Ophthalmology 2023; 107: 973-979
